Works matching DE "NON-muscle invasive bladder cancer"
Results: 476
BLADDER CANCER. The economics of bladder cancer in the US: Increasing costs and unsustainable patterns.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
UroPipeline.
- Published in:
- Urology Times, 2025, v. 53, n. 2, p. 24
- By:
- Publication type:
- Article
Conference Highlights. 25TH ANNUAL MEETING OF THE SOCIETY OF UROLOGIC ONCOLOGY.
- Published in:
- 2025
- By:
- Publication type:
- Abstract
NMIBC highlights at SUO 2024.
- Published in:
- Urology Times, 2025, v. 53, n. 2, p. 11
- By:
- Publication type:
- Article
Mean platelet volume to lymphocyte ratio as an inflammatory marker associated with high-grade recurrence and progression of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin.
- Published in:
- Central European Journal of Urology (2080-4806), 2024, v. 77, n. 4, p. 59, doi. 10.5173/ceju.2024.0118
- By:
- Publication type:
- Article
Therapeutic Advances in Bladder Preservation for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 636, doi. 10.3390/cancers17040636
- By:
- Publication type:
- Article
The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 628, doi. 10.3390/cancers17040628
- By:
- Publication type:
- Article
The Effect of Bladder Outlet Obstruction on Bladder Cancer Recurrence and Progression.
- Published in:
- Journal of Urological Surgery, 2025, v. 12, n. 1, p. 1, doi. 10.4274/jus.galenos.2024.2024-10-6
- By:
- Publication type:
- Article
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 1, p. 1, doi. 10.1007/s40267-024-01045-0
- By:
- Publication type:
- Article
The potential of interleukin-17 inhibitors treatment for reactive arthritis after transurethral resection of a bladder tumor and intravesical administration of bacillus calmette-guerin therapy.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
ABSTRACTS.
- Published in:
- 2023
- Publication type:
- Abstract
血清 irisin, DJ-1 与非肌层浸润性膀胱癌患者 TURBT 术后复发的 关系研究.
- Published in:
- Progress in Modern Biomedicine, 2024, v. 24, n. 17, p. 3274, doi. 10.13241/j.cnki.pmb.2024.17.015
- By:
- Publication type:
- Article
Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-83976-2
- By:
- Publication type:
- Article
Nomogram for predicting all-cause mortality and cancer-specific mortality after TURBT for non-muscle-invasive bladder cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-80333-1
- By:
- Publication type:
- Article
Precise grading of non-muscle invasive bladder cancer with multi-scale pyramidal CNN.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-77101-6
- By:
- Publication type:
- Article
Potential utility of ADNP in circulating tumor cells as biomarker for prognostics in non-muscle-invasive bladder cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70379-6
- By:
- Publication type:
- Article
Prediction of non-muscle invasive bladder cancer recurrence using deep learning of pathology image.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-66870-9
- By:
- Publication type:
- Article
Optimal timing for the first cystoscopic follow-up using time-to-treatment initiation analysis of oncologic outcomes in primary non-muscle invasive bladder cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58809-x
- By:
- Publication type:
- Article
Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58586-7
- By:
- Publication type:
- Article
Peripheral Mechanisms Underlying Bacillus Calmette–Guerin-Induced Lower Urinary Tract Symptoms (LUTS).
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 12, p. 1203, doi. 10.3390/brainsci14121203
- By:
- Publication type:
- Article
Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry.
- Published in:
- Clinical Epidemiology, 2022, v. 14, p. 1317, doi. 10.2147/CLEP.S376566
- By:
- Publication type:
- Article
Geriatric assessment‐derived deficit accumulation and patient‐reported treatment burden in older adults with bladder cancer.
- Published in:
- Journal of the American Geriatrics Society, 2024, v. 72, n. 2, p. 490, doi. 10.1111/jgs.18676
- By:
- Publication type:
- Article
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01897-6
- By:
- Publication type:
- Article
Urinary microRNA-10a levels in diagnosis and prognosis of urinary bladder cancer.
- Published in:
- Journal of Cancer Research & Therapeutics, 2023, v. 19, n. 5, p. 1324, doi. 10.4103/jcrt.jcrt_1014_21
- By:
- Publication type:
- Article
PREFACE — APPLICATION AND PROGRESS OF BIOMECHANICS IN MEDICINE-PART I.
- Published in:
- Journal of Mechanics in Medicine & Biology, 2024, v. 24, n. 2, p. 1, doi. 10.1142/S0219519424020019
- By:
- Publication type:
- Article
Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e230849, doi. 10.1001/jamanetworkopen.2023.0849
- By:
- Publication type:
- Article
Patterns in the Management of Low-Grade Non–Muscle-Invasive Bladder Cancer—the Human and Economic Costs of Excessive Surveillance.
- Published in:
- 2022
- By:
- Publication type:
- Opinion
Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non–Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e223050, doi. 10.1001/jamanetworkopen.2022.3050
- By:
- Publication type:
- Article
The Effect of Glutathione on Development and Prognosis in Non-Muscle-Invasive Bladder Cancer.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5483, doi. 10.3390/jcm13185483
- By:
- Publication type:
- Article
Contemporary Treatment of NMIBC—Is It Time to Move on from BCG?
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 14, p. 4112, doi. 10.3390/jcm13144112
- By:
- Publication type:
- Article
Integrating the PD-L1 Prognostic Biomarker in Non-Muscle Invasive Bladder Cancer in Clinical Practice—A Comprehensive Review on State-of-the-Art Advances and Critical Issues.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2182, doi. 10.3390/jcm13082182
- By:
- Publication type:
- Article
Plasma-Derived Cell-Free DNA as a Biomarker for Early Detection, Prognostication, and Personalized Treatment of Urothelial Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 2057, doi. 10.3390/jcm13072057
- By:
- Publication type:
- Article
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 2031, doi. 10.3390/jcm13072031
- By:
- Publication type:
- Article
FGFR3 Mutations in Urothelial Carcinoma: A Single-Center Study Using Next-Generation Sequencing.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1305, doi. 10.3390/jcm13051305
- By:
- Publication type:
- Article
A Systematic Review on the Role of Repeat Transurethral Resection after Initial en Bloc Resection for Non-Muscle Invasive Bladder Cancer.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5049, doi. 10.3390/jcm11175049
- By:
- Publication type:
- Article
Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea.
- Published in:
- Investigative & Clinical Urology, 2024, v. 65, n. 5, p. 435, doi. 10.4111/icu.20240047
- By:
- Publication type:
- Article
Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.
- Published in:
- Investigative & Clinical Urology, 2024, v. 65, n. 3, p. 279, doi. 10.4111/icu.20230284
- By:
- Publication type:
- Article
Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study
- Published in:
- Investigative & Clinical Urology, 2024, v. 65, n. 3, p. 248, doi. 10.4111/icu.20230313
- By:
- Publication type:
- Article
COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype.
- Published in:
- Investigative & Clinical Urology, 2024, v. 65, n. 1, p. 94, doi. 10.4111/icu.20230227
- By:
- Publication type:
- Article
The effect of immediate neoadjuvant electromotive instillation of mitomycin C with Bacillus Calmette--Guérin versus BCG alone in non-muscle-invasive bladder cancer: A randomized controlled trial.
- Published in:
- Investigative & Clinical Urology, 2023, v. 64, n. 6, p. 554, doi. 10.4111/icu.20230161
- By:
- Publication type:
- Article
Accuracy of Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer detection from multiparametric magnetic resonance imaging.
- Published in:
- Investigative & Clinical Urology, 2023, v. 64, n. 6, p. 546, doi. 10.4111/icu.20230120
- By:
- Publication type:
- Article
Treatment strategies for the Bacillus Calmette-Guérin--unresponsive non-muscle invasive bladder cancer.
- Published in:
- Investigative & Clinical Urology, 2023, v. 64, n. 2, p. 103, doi. 10.4111/icu.20230042
- Publication type:
- Article
Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain.
- Published in:
- Biomedicines, 2025, v. 13, n. 1, p. 174, doi. 10.3390/biomedicines13010174
- By:
- Publication type:
- Article
Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies.
- Published in:
- Biomedicines, 2025, v. 13, n. 1, p. 156, doi. 10.3390/biomedicines13010156
- By:
- Publication type:
- Article
A Pilot Study of the Role of Semaphorin 4A (sema4A) and 3C (sema3C) in Non-Muscle-Invasive Bladder Cancer (NMIBC).
- Published in:
- Biomedicines, 2024, v. 12, n. 10, p. 2407, doi. 10.3390/biomedicines12102407
- By:
- Publication type:
- Article
Blood Extracellular Vesicles Beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients.
- Published in:
- Biomedicines, 2024, v. 12, n. 10, p. 2359, doi. 10.3390/biomedicines12102359
- By:
- Publication type:
- Article
The Role of Semaphorin 6D (Sema6D) in Non-Muscle-Invasive Bladder Cancer—A Preliminary Study on Human Plasma and Urine.
- Published in:
- Biomedicines, 2024, v. 13, n. 7, p. 1426, doi. 10.3390/biomedicines12071426
- By:
- Publication type:
- Article
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result.
- Published in:
- Biomedicines, 2023, v. 11, n. 12, p. 3288, doi. 10.3390/biomedicines11123288
- By:
- Publication type:
- Article
Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette–Guérin.
- Published in:
- Biomedicines, 2023, v. 11, n. 11, p. 3062, doi. 10.3390/biomedicines11113062
- By:
- Publication type:
- Article